M D Fuller - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M D Fuller

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Antiviral Research|January 27, 1998

In vitro characterization of the anti-human cytomegalovirus activity of PMEA (Adefovir)X Xiong, C Flores, M D Fuller, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|August 21, 2001

Adefovir and tenofovir susceptibilities of HIV-1 after 24 to 48 weeks of adefovir dipivoxil therapy: genotypic and phenotypic analyses of study GS-96-408M D Miller, N A Margot, P D Lamy, et al.

Antimicrobial Agents and Chemotherapy|May 1, 1996

Comparative kinetic analyses of interaction of inhibitors with Rauscher murine leukemia virus and human immunodeficiency virus reverse transcriptasesJ M Cherrington, M D Fuller, A S Mulato, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Antiviral Research|January 27, 1998

In vitro characterization of the anti-human cytomegalovirus activity of PMEA (Adefovir)X Xiong, C Flores, M D Fuller, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|August 21, 2001

Adefovir and tenofovir susceptibilities of HIV-1 after 24 to 48 weeks of adefovir dipivoxil therapy: genotypic and phenotypic analyses of study GS-96-408M D Miller, N A Margot, P D Lamy, et al.

Antimicrobial Agents and Chemotherapy|May 1, 1996

Comparative kinetic analyses of interaction of inhibitors with Rauscher murine leukemia virus and human immunodeficiency virus reverse transcriptasesJ M Cherrington, M D Fuller, A S Mulato, et al.

Pageof 2